The Cambridge Pancreatic Cancer Centre (CPCC) aims to be a centre of multidisciplinary excellence for the translation of pancreatic cancer research.
The Centre aims to enrol as many pancreatic cancer patients as possible onto clinical trials so that they may benefit from novel therapeutic approaches, while permitting us to further our understanding of this disease and generate better therapies in the future.
Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.